International Journal of Clinical Oncology

Search all International Journal of Clinical Oncology articles

Volume 29, Issue 8

August 2024

Including Invited Reviews on Current status and future perspective of immunotherapy for urothelial and renal cancer

19 articles in this issue

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for gastric and biliary tract cancer and encorafenib and binimetinib for thyroid cancer in Japan
Noriomi Matsumura
Masaki Mandai
PMDA Regulatory Update 05 June 2024 Pages: 1053 - 1054
Part of 1 collection:

PMDA regulatory updates
Pancreatic cancer and sarcopenia: a narrative review of the current status
Mariko Tsukagoshi
Kenichiro Araki
Ken Shirabe
JSCO Board of Directors Series 02 July 2024 Pages: 1055 - 1066
Part of 1 collection:

JSCO Board of Directors Series
Primary prophylaxis with G-CSF for patients with non-round cell soft tissue sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology
Takeshi Hirose
Mamoru Ito
Makoto Endo
Special Article 12 June 2024 Pages: 1067 - 1073
Part of 1 collection:

Clinical Practice Guidelines for the Use of G-CSF 2022 and related articles
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022
Kazuki Nozawa
Yukinori Ozaki
Toshimi Takano
Special Article 20 June 2024 Pages: 1074 - 1080
Part of 1 collection:

Clinical Practice Guidelines for the Use of G-CSF 2022 and related articles
Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology
Takeshi Hirose
Mamoru Ito
Makoto Endo
Special Article 21 June 2024 Pages: 1081 - 1087
Part of 1 collection:

Clinical Practice Guidelines for the Use of G-CSF 2022 and related articles
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan
Takeshi Sasaki
Takahiro Higashi
Takahiro Inoue
Cancer Statistics 02 July 2024 Pages: 1088 - 1095
Part of 1 collection:

Cancer Statistics
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution
Atsunari Kawashima
Yu Ishizuya
Norio Nonomura
Invited Review Article Open access 08 June 2024 Pages: 1096 - 1104
Current status and future perspective of immunotherapy for renal cell carcinoma
Leandro Blas
Keisuke Monji
Masatoshi Eto
Invited Review Article 18 December 2023 Pages: 1105 - 1114
The efficacy and safety of anamorelin among patients with diabetes
Kenju Ando
Tateaki Naito
Toshiaki Takahashi
Original Article 09 May 2024 Pages: 1115 - 1121
Prognostic value of a mandibular canal staging system for primary lesions in patients with lower gingival squamous cell carcinoma: a multicenter, retrospective study
Nobuhiro Yamakawa
Masaya Okura
Japan Oral Oncology Group (JOOG)
Original Article 02 May 2024 Pages: 1122 - 1132
Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
Ryoko Tanaka
Yushi Ueki
Arata Horii
Original Article 10 May 2024 Pages: 1133 - 1141
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study
Kaname Nosaki
Kiyotaka Yoh
Koichi Goto
Original Article 17 May 2024 Pages: 1142 - 1151
Prognostic impact of the combination of p16^INK4a, p21 and Immunoscore in rectal cancer
Toshihiro Nakao
Mitsuo Shimada
Toshiaki Yoshimoto
Original Article 19 June 2024 Pages: 1152 - 1160
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan
Ryo Takahashi
Hiroki Osumi
Eiji Shinozaki
Original Article 31 May 2024 Pages: 1161 - 1172
Zinc supplementation for dysgeusia in patients with unresectable pancreatic cancer
Yusuke Seiki
Kenji Ikezawa
Kazuyoshi Ohkawa
Original Article 10 May 2024 Pages: 1173 - 1181
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm
Ryosuke Fukushima
Norifumi Harimoto
Ken Shirabe
Original Article 20 May 2024 Pages: 1182 - 1190
Effectiveness and safety of enzalutamide and apalutamide in the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC): a multicenter retrospective study
Shuhei Hara
Keiichiro Mori
Takahiro Kimura
Original Article 20 May 2024 Pages: 1191 - 1197
Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI)
Kazuhiro Matsumoto
Takeo Kosaka
Mototsugu Oya
Original Article Open access 10 June 2024 Pages: 1198 - 1203
Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy
Tsutomu Nishida
Kana Hosokawa
Aya Sugimoto
Letter to the Editor 03 June 2024 Pages: 1204 - 1205

Volume 29, Issue 8

Journal navigation